Abeona Therapeutics, Inc. (ABEO)
4.41
-0.02
(-0.45%)
USD |
NASDAQ |
Oct 19, 16:00
4.41
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Profit Margin (Quarterly) : -177.4% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -177.4% |
| March 31, 2026 | -195.8% |
| December 31, 2025 | -377.5% |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | -475.8% |
| March 31, 2023 | |
| December 31, 2022 | -1.66K% |
| September 30, 2022 | |
| June 30, 2022 | -409.7% |
| March 31, 2022 | -6.37K% |
| December 31, 2021 | -1.56K% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -527.6% |
| September 30, 2020 | -103.4% |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| September 30, 2018 | -960.7% |
| June 30, 2018 | -4.44K% |
| March 31, 2018 | -1.98K% |
| December 31, 2017 | -3.93K% |
| September 30, 2017 | -2.44K% |
| June 30, 2017 | -3.82K% |
| March 31, 2017 | -2.82K% |
| December 31, 2016 | -2.74K% |
| September 30, 2016 | -1.43K% |
| June 30, 2016 | -3.13K% |
| March 31, 2016 | -2.36K% |
| December 31, 2015 | -1.09K% |
| September 30, 2015 | -2.13K% |
| June 30, 2015 | -1.46K% |
| March 31, 2015 | -775.2% |
| December 31, 2014 | -5.10K% |
| September 30, 2014 | -622.5% |
| June 30, 2014 | -5.06K% |
| March 31, 2014 | -413.0% |
| December 31, 2013 | -663.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -42.99% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.99% |
| Return on Assets | -29.21% |
| Return on Invested Capital | -35.60% |
| Gross Profit Margin (Quarterly) | 57.45% |
| Operating Margin (Quarterly) | -120.0% |
| Return on Net Operating Assets | -267.7% |